Latest Breaking News On - Edmond chan - Page 5 : vimarsana.com

ASCIA 2023 Conference: towards oral immunotherapy s clinical use in Australia for food adverse conditions

The ASCIA 2023 Conference was held at the International Convention Centre (ICC) Sydney from Tuesday 5th to Friday 8th September 2023, as a hybrid conference, which enabled in-person and virtual attendance. There some highlights brought by Dr Nina Marković:

Darling harbourNew south walesSouth australiaNew zealandUnited statesWestern australiaRichard lohDouglash jonesNina markoviEdmond chanJovanka kingAdelaide convention centreAustralasian society of clinical immunologyAustralasian societyClinical immunologyContinuing professional development

Janssen s Tecvayli approved by EC for reduced dosing frequency in multiple myeloma

Janssen s Tecvayli approved by EC for reduced dosing frequency in multiple myeloma
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Edmond chanJanssen tecvayliEuropean commissionDrug administration

Talquetamab Wins Approval in Europe for Relapsed/Refractory Myeloma

The European Commission has granted conditional marketing authorization to talquetamab-tgvs monotherapy for the treatment of patients with relapsed/refractory multiple myeloma who have received at least 3 prior therapies and have demonstrated disease progression on the last therapy.

Edmond chanMaria victoria mateosEuropean commissionUniversity hospital of salamancaVictoria mateosUniversity hospitalMultiple myeloma

Janssen granted additional European Commission approval for bispecific antibody

Janssen, a Johnson & Johnson company, has announced that its bispecific antibody has been granted approval by the European Commission (EC) for use in certain patients with relapsed or refractory multiple myeloma (RRMM).

Noord hollandUnited statesEdmond chanSen zhuangEuropean commissionAmerican society of clinical oncologyAmsterdam university medical centersEuropean hematology associationClinical oncologyAnnual meetingHematology associationBio developmentsEmerging marketsOhnson amp johnsonBispecific antibodiesEuropean commission

European Commission Approves Reduced Dosing of Teclistamab in Relapsed/Refractory Myeloma

European Commission Approves Reduced Dosing of Teclistamab in Relapsed/Refractory Myeloma
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Noord hollandEdmond chanTherapeutic area in hematology at janssen cilagEuropean commissionAmsterdam university medical centersJanssen cilag limited